Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01946204
Title A Study of Apalutamide (ARN-509) in Men With Non-Metastatic Castration-Resistant Prostate Cancer (SPARTAN)
Recruitment Active, not recruiting
Gender male
Phase Phase III
Variant Requirements No
Sponsors Aragon Pharmaceuticals, Inc.
Indications

prostate adenocarcinoma

Therapies

Apalutamide

Age Groups: senior | adult
Covered Countries USA | FRA | ESP | DEU | CAN | BEL | AUT


No variant requirements are available.